{"id":43095,"date":"2024-06-03T14:40:17","date_gmt":"2024-06-03T14:40:17","guid":{"rendered":"https:\/\/www.elza-institute.com\/?p=43095"},"modified":"2024-06-03T14:47:07","modified_gmt":"2024-06-03T14:47:07","slug":"democratizing-corneal-cross-linking-2","status":"publish","type":"post","link":"https:\/\/www.elza-institute.com\/pt\/democratizing-corneal-cross-linking-2\/","title":{"rendered":"Democratizar o cross-linking da c\u00f3rnea"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

O Instituto ELZA liderou uma iniciativa que est\u00e1 a levar \u00e0 \"democratiza\u00e7\u00e3o\" do cross-linking corneano (CXL), com o objetivo de tornar este procedimento corneano que salva a vis\u00e3o acess\u00edvel a n\u00edvel mundial, especialmente nos pa\u00edses de rendimento baixo a m\u00e9dio (LMIC). Um artigo recente sobre o Ag\u00eancia Internacional para a Preven\u00e7\u00e3o da Cegueira (IAPB)<\/a> apresenta uma entrevista com o Dr. Mark Hillen<\/a> com Prof. Farhad Hafezi<\/a> e Dr. Emilio Torres-Netto<\/a> exatamente sobre este tema. Neste artigo, os nossos cirurgi\u00f5es explicam que o CXL tem sido tradicionalmente um procedimento complexo realizado em ambientes hospitalares. No entanto, os avan\u00e7os dos investigadores do ELZA, incluindo o , est\u00e3o a revolucionar esta situa\u00e7\u00e3o, tornando o CXL port\u00e1til e acess\u00edvel.<\/p>

\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"Antevis\u00e3o\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

O Prof. Hafezi explica no artigo a import\u00e2ncia do CXL: \"Tradicionalmente, doen\u00e7as como o ceratocone e as infecciosas requeriam tratamento num hospital. O ceratocone \u00e9 a principal causa de cegueira evit\u00e1vel entre crian\u00e7as e adolescentes em todo o mundo. O que acontece \u00e9 que a c\u00f3rnea fica cada vez mais fraca. Como o olho \u00e9 pressurizado, a parte enfraquecida come\u00e7a a ficar saliente para fora em forma de cone. \u00c0 medida que o cone cresce, a vis\u00e3o das pessoas piora. Historicamente, o \u00fanico tratamento era um transplante de c\u00f3rnea, mas nos \u00faltimos 20 anos, temos conseguido fortalecer a c\u00f3rnea e impedir a progress\u00e3o da doen\u00e7a utilizando um tratamento chamado cross-linking corneano (CXL) - e o CXL reduziu drasticamente o n\u00famero de cirurgias de transplante de c\u00f3rnea necess\u00e1rias para tratar o ceratocone\".<\/p>

O Dr. Torres-Netto acrescenta: \"O problema \u00e9 que, at\u00e9 h\u00e1 relativamente pouco tempo, o CXL tem sido realizado maioritariamente em blocos operat\u00f3rios dentro dos hospitais. Os blocos operat\u00f3rios t\u00eam de ser completamente esterilizados, dotados de pessoal e reservados com semanas de anteced\u00eancia, uma vez que os cirurgi\u00f5es competem pelo espa\u00e7o do bloco operat\u00f3rio. Este facto torna o procedimento muito dispendioso. Muitas vezes, o problema \u00e9 que nos pa\u00edses de baixa e m\u00e9dia renda, a maioria da popula\u00e7\u00e3o vive em regi\u00f5es rurais, enquanto os hospitais est\u00e3o concentrados numa ou duas cidades. Nos pa\u00edses de baixa e m\u00e9dia renda, n\u00e3o \u00e9 s\u00f3 o custo do procedimento no hospital que pode ser proibitivo, \u00e9 tamb\u00e9m o custo do tempo e da desloca\u00e7\u00e3o at\u00e9 ao hospital que impede as pessoas de receberem o procedimento. Em casos extremos, muitas cidades ou aldeias nem sequer t\u00eam hospitais ou centros cir\u00fargicos e, muitas vezes, pode demorar dias a l\u00e1 chegar. J\u00e1 tive esta experi\u00eancia v\u00e1rias vezes ao viajar por cidades ribeirinhas no meio da floresta amaz\u00f3nica\".<\/p>

Estes avan\u00e7os permitem que o CXL seja efectuado fora dos locais tradicionais, reduzindo os custos e aumentando a acessibilidade. O artigo salienta que est\u00e3o agora dispon\u00edveis dispositivos CXL port\u00e1teis inovadores que podem ser utilizados com l\u00e2mpadas de fenda, e que as l\u00e2mpadas de fenda s\u00e3o quase omnipresentes nos cuidados oftalmol\u00f3gicos, ou mesmo nos locais mais remotos. Este salto tecnol\u00f3gico n\u00e3o s\u00f3 torna o procedimento mais acess\u00edvel, como tamb\u00e9m reduz significativamente os custos, tornando-o vi\u00e1vel para os pa\u00edses de baixa e m\u00e9dia renda, onde os recursos de sa\u00fade s\u00e3o frequentemente limitados.<\/p>

Os esfor\u00e7os do ELZA alinham-se com objectivos mais amplos de equidade na sa\u00fade global, abordando as disparidades no acesso aos cuidados oftalmol\u00f3gicos. O desenvolvimento destes dispositivos port\u00e1teis \u00e9 visto pelos entrevistados como um fator de mudan\u00e7a, permitindo que mais doentes recebam tratamento atempado e eficaz.<\/p>

\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dr. Torres-Netto: \"A luz UV emitida durante o processo de reticula\u00e7\u00e3o n\u00e3o se importa se est\u00e1 a ser emitida a partir de cima, com o doente deitado ou sentado na vertical na l\u00e2mpada de fenda. Fizemos o trabalho para mostrar que a riboflavina no olho tamb\u00e9m n\u00e3o se deposita para baixo quando o doente est\u00e1 sentado na vertical. Mostr\u00e1mos recentemente que o CXL na l\u00e2mpada de fenda \u00e9 t\u00e3o eficaz e seguro como o CXL realizado no bloco operat\u00f3rio\".<\/p>

Ao tornar o CXL port\u00e1til e acess\u00edvel, a ELZA est\u00e1 a preparar o caminho para um acesso mais alargado a servi\u00e7os essenciais de cuidados oftalmol\u00f3gicos, particularmente em ambientes com recursos limitados.<\/p>

O Dr. Torres-Netto acrescenta: \"O problema \u00e9 que, at\u00e9 h\u00e1 relativamente pouco tempo, o CXL tem sido realizado maioritariamente em blocos operat\u00f3rios dentro dos hospitais. Os blocos operat\u00f3rios t\u00eam de ser completamente esterilizados, dotados de pessoal e reservados com semanas de anteced\u00eancia, uma vez que os cirurgi\u00f5es competem pelo espa\u00e7o do bloco operat\u00f3rio. Este facto torna o procedimento muito dispendioso. Muitas vezes, o problema \u00e9 que nos pa\u00edses de baixa e m\u00e9dia renda, a maioria da popula\u00e7\u00e3o vive em regi\u00f5es rurais, enquanto os hospitais est\u00e3o concentrados numa ou duas cidades. Nos pa\u00edses de baixa e m\u00e9dia renda, n\u00e3o \u00e9 s\u00f3 o custo do procedimento no hospital que pode ser proibitivo, \u00e9 tamb\u00e9m o custo do tempo e da desloca\u00e7\u00e3o at\u00e9 ao hospital que impede as pessoas de receberem o procedimento. Em casos extremos, muitas cidades ou aldeias nem sequer t\u00eam hospitais ou centros cir\u00fargicos e, muitas vezes, pode demorar dias a l\u00e1 chegar. J\u00e1 tive esta experi\u00eancia v\u00e1rias vezes ao viajar por cidades ribeirinhas no meio da floresta amaz\u00f3nica\".<\/p>

Estes avan\u00e7os permitem que o CXL seja efectuado fora dos locais tradicionais, reduzindo os custos e aumentando a acessibilidade. O artigo salienta que est\u00e3o agora dispon\u00edveis dispositivos CXL port\u00e1teis inovadores que podem ser utilizados com l\u00e2mpadas de fenda, e que as l\u00e2mpadas de fenda s\u00e3o quase omnipresentes nos cuidados oftalmol\u00f3gicos, ou mesmo nos locais mais remotos. Este salto tecnol\u00f3gico n\u00e3o s\u00f3 torna o procedimento mais acess\u00edvel, como tamb\u00e9m reduz significativamente os custos, tornando-o vi\u00e1vel para os pa\u00edses de baixa e m\u00e9dia renda, onde os recursos de sa\u00fade s\u00e3o frequentemente limitados.<\/p>

Os esfor\u00e7os do ELZA alinham-se com objectivos mais amplos de equidade na sa\u00fade global, abordando as disparidades no acesso aos cuidados oftalmol\u00f3gicos. O desenvolvimento destes dispositivos port\u00e1teis \u00e9 visto pelos entrevistados como um fator de mudan\u00e7a, permitindo que mais doentes recebam tratamento atempado e eficaz.<\/p>

Dr. Torres-Netto: \"A luz UV emitida durante o processo de reticula\u00e7\u00e3o n\u00e3o se importa se est\u00e1 a ser emitida a partir de cima, com o doente deitado ou sentado na vertical na l\u00e2mpada de fenda. Fizemos o trabalho para mostrar que a riboflavina no olho tamb\u00e9m n\u00e3o se deposita para baixo quando o doente est\u00e1 sentado na vertical. Mostr\u00e1mos recentemente que o CXL na l\u00e2mpada de fenda \u00e9 t\u00e3o eficaz e seguro como o CXL realizado no bloco operat\u00f3rio\".<\/p>

Ao tornar o CXL port\u00e1til e acess\u00edvel, a ELZA est\u00e1 a preparar o caminho para um acesso mais alargado a servi\u00e7os essenciais de cuidados oftalmol\u00f3gicos, particularmente em ambientes com recursos limitados.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

A investiga\u00e7\u00e3o da ELZA levou ao desenvolvimento de dispositivos port\u00e1teis de reticula\u00e7\u00e3o da c\u00f3rnea que democratizam o acesso a cuidados oftalmol\u00f3gicos essenciais, transformando o tratamento do ceratocone e da ceratite infecciosa em pa\u00edses de rendimento baixo a m\u00e9dio.<\/p>","protected":false},"author":4,"featured_media":43107,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[243,214],"tags":[125,130,100],"class_list":["post-43095","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-emilio-torres","category-farhad-hafezi","tag-cornea","tag-cross-linking","tag-cxl"],"acf":[],"yoast_head":"\nDemocratizing corneal cross-linking - The ELZA Institute<\/title>\n<meta name=\"description\" content=\"The International Association for the Prevention of Blindness (IAPB) ask ELZA about "democratizing corneal cross-linking" (CXL).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.elza-institute.com\/pt\/democratizing-corneal-cross-linking-2\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Democratizing corneal cross-linking - The ELZA Institute\" \/>\n<meta property=\"og:description\" content=\"The International Association for the Prevention of Blindness (IAPB) ask ELZA about "democratizing corneal cross-linking" (CXL).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.elza-institute.com\/pt\/democratizing-corneal-cross-linking-2\/\" \/>\n<meta property=\"og:site_name\" content=\"The ELZA Institute\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ELZA.Institute\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-03T14:40:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-03T14:47:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/06\/Democratising-corneal-cross-linking.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mark Hillen\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark Hillen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/democratizing-corneal-cross-linking-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/democratizing-corneal-cross-linking-2\\\/\"},\"author\":{\"name\":\"Mark Hillen\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/person\\\/e3929262886a5a60dd6965a6bc721d15\"},\"headline\":\"Democratizing corneal cross-linking\",\"datePublished\":\"2024-06-03T14:40:17+00:00\",\"dateModified\":\"2024-06-03T14:47:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/democratizing-corneal-cross-linking-2\\\/\"},\"wordCount\":952,\"publisher\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/democratizing-corneal-cross-linking-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Democratising-corneal-cross-linking.jpg\",\"keywords\":[\"Cornea\",\"Cross-Linking\",\"CXL\"],\"articleSection\":[\"Emilio Torres\",\"Farhad Hafezi\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/democratizing-corneal-cross-linking-2\\\/\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/democratizing-corneal-cross-linking-2\\\/\",\"name\":\"Democratizing corneal cross-linking - The ELZA Institute\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/democratizing-corneal-cross-linking-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/democratizing-corneal-cross-linking-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Democratising-corneal-cross-linking.jpg\",\"datePublished\":\"2024-06-03T14:40:17+00:00\",\"dateModified\":\"2024-06-03T14:47:07+00:00\",\"description\":\"The International Association for the Prevention of Blindness (IAPB) ask ELZA about \\\"democratizing corneal cross-linking\\\" (CXL).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/democratizing-corneal-cross-linking-2\\\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.elza-institute.com\\\/democratizing-corneal-cross-linking-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/democratizing-corneal-cross-linking-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Democratising-corneal-cross-linking.jpg\",\"contentUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Democratising-corneal-cross-linking.jpg\",\"width\":1280,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/democratizing-corneal-cross-linking-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.elza-institute.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Farhad Hafezi\",\"item\":\"https:\\\/\\\/www.elza-institute.com\\\/farhad-hafezi\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Democratizing corneal cross-linking\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#website\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/\",\"name\":\"The ELZA Institute\",\"description\":\"Swiss EyeCare at its finest\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.elza-institute.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#organization\",\"name\":\"The ELZA Institute\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2016\\\/04\\\/ELZA-logo-V4.jpg\",\"contentUrl\":\"https:\\\/\\\/www.elza-institute.com\\\/wp-content\\\/uploads\\\/2016\\\/04\\\/ELZA-logo-V4.jpg\",\"width\":1181,\"height\":453,\"caption\":\"The ELZA Institute\"},\"image\":{\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ELZA.Institute\\\/\",\"https:\\\/\\\/x.com\\\/ELZA_Institute\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/elza-institute?trk=top_nav_home\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.elza-institute.com\\\/#\\\/schema\\\/person\\\/e3929262886a5a60dd6965a6bc721d15\",\"name\":\"Mark Hillen\",\"url\":\"https:\\\/\\\/www.elza-institute.com\\\/pt\\\/author\\\/markhillen\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Democratizar o cross-linking da c\u00f3rnea - Instituto ELZA","description":"A Associa\u00e7\u00e3o Internacional para a Preven\u00e7\u00e3o da Cegueira (IAPB) pergunta \u00e0 ELZA sobre a \"democratiza\u00e7\u00e3o do cross-linking corneano\" (CXL).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.elza-institute.com\/pt\/democratizing-corneal-cross-linking-2\/","og_locale":"pt_PT","og_type":"article","og_title":"Democratizing corneal cross-linking - The ELZA Institute","og_description":"The International Association for the Prevention of Blindness (IAPB) ask ELZA about \"democratizing corneal cross-linking\" (CXL).","og_url":"https:\/\/www.elza-institute.com\/pt\/democratizing-corneal-cross-linking-2\/","og_site_name":"The ELZA Institute","article_publisher":"https:\/\/www.facebook.com\/ELZA.Institute\/","article_published_time":"2024-06-03T14:40:17+00:00","article_modified_time":"2024-06-03T14:47:07+00:00","og_image":[{"width":1280,"height":600,"url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/06\/Democratising-corneal-cross-linking.jpg","type":"image\/jpeg"}],"author":"Mark Hillen","twitter_misc":{"Escrito por":"Mark Hillen","Tempo estimado de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.elza-institute.com\/democratizing-corneal-cross-linking-2\/#article","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/democratizing-corneal-cross-linking-2\/"},"author":{"name":"Mark Hillen","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15"},"headline":"Democratizing corneal cross-linking","datePublished":"2024-06-03T14:40:17+00:00","dateModified":"2024-06-03T14:47:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.elza-institute.com\/democratizing-corneal-cross-linking-2\/"},"wordCount":952,"publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"image":{"@id":"https:\/\/www.elza-institute.com\/democratizing-corneal-cross-linking-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/06\/Democratising-corneal-cross-linking.jpg","keywords":["Cornea","Cross-Linking","CXL"],"articleSection":["Emilio Torres","Farhad Hafezi"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/www.elza-institute.com\/democratizing-corneal-cross-linking-2\/","url":"https:\/\/www.elza-institute.com\/democratizing-corneal-cross-linking-2\/","name":"Democratizar o cross-linking da c\u00f3rnea - Instituto ELZA","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.elza-institute.com\/democratizing-corneal-cross-linking-2\/#primaryimage"},"image":{"@id":"https:\/\/www.elza-institute.com\/democratizing-corneal-cross-linking-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/06\/Democratising-corneal-cross-linking.jpg","datePublished":"2024-06-03T14:40:17+00:00","dateModified":"2024-06-03T14:47:07+00:00","description":"A Associa\u00e7\u00e3o Internacional para a Preven\u00e7\u00e3o da Cegueira (IAPB) pergunta \u00e0 ELZA sobre a \"democratiza\u00e7\u00e3o do cross-linking corneano\" (CXL).","breadcrumb":{"@id":"https:\/\/www.elza-institute.com\/democratizing-corneal-cross-linking-2\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.elza-institute.com\/democratizing-corneal-cross-linking-2\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/democratizing-corneal-cross-linking-2\/#primaryimage","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/06\/Democratising-corneal-cross-linking.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2024\/06\/Democratising-corneal-cross-linking.jpg","width":1280,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/www.elza-institute.com\/democratizing-corneal-cross-linking-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.elza-institute.com\/"},{"@type":"ListItem","position":2,"name":"Farhad Hafezi","item":"https:\/\/www.elza-institute.com\/farhad-hafezi\/"},{"@type":"ListItem","position":3,"name":"Democratizing corneal cross-linking"}]},{"@type":"WebSite","@id":"https:\/\/www.elza-institute.com\/#website","url":"https:\/\/www.elza-institute.com\/","name":"O Instituto ELZA","description":"Swiss EyeCare no seu melhor","publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.elza-institute.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/www.elza-institute.com\/#organization","name":"O Instituto ELZA","url":"https:\/\/www.elza-institute.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","width":1181,"height":453,"caption":"The ELZA Institute"},"image":{"@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ELZA.Institute\/","https:\/\/x.com\/ELZA_Institute","https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home"]},{"@type":"Person","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/e3929262886a5a60dd6965a6bc721d15","name":"Mark Hillen","url":"https:\/\/www.elza-institute.com\/pt\/author\/markhillen\/"}]}},"_links":{"self":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/43095","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/comments?post=43095"}],"version-history":[{"count":0,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/43095\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media\/43107"}],"wp:attachment":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media?parent=43095"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/categories?post=43095"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/tags?post=43095"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}